Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. The Company's business is in one operating segment: life science.
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
PTN Insider Transactions (Form 4)
53
19 Form 4 filings on record, the earliest from May 13, 2025, newest first.
PALATIN TECHNOLOGIES INC (PTN) had 5 insider filings in the last 90 days, with the most recent on 2026-08-05. The full record for PTN runs to 19 Form 4 filings, the earliest from 2025-05-13. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying PTN stock?
No insider purchases of PTN were filed in the last 90 days. 7 purchases are on record for this company.
How many insiders are selling PTN stock?
No insider sales of PTN were filed in the last 90 days. 1 sale is on record for this company.
Where can I see PTN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks PTN Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow PTN insider buys?
Create a free InsiderAlpha account and press Watch on this page to add PTN to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
